GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
top of page
Headlines
GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
Research
Journal Watch 12/3/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Ascletis reveals pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection
Ascletis Pharma has announced pharmacokinetic and weight loss data from its ASC47 Phase Ib single subcutaneous injection studies in...
GT Metabolic expands MagDI System with FDA clearance of 50mm magnet
The FDA has cleared GT Metabolic Solutions’ larger, 50mm MagDISystem magnet to complement the system's existing 40mm magnet. This...
OMP reveals additional three-month data for its Sirona dual-polymer hydrogel pill
Oxford Medical Products (OMP) has announced the additional three-month clinical trial results for Sirona, a weight-loss treatment...
Genome-edited stem cells offer hope for obesity treatment without muscle loss
Researchers at the Beijing Institute of Stem Cells and Regeneration (BISCRM) and the Institute of Zoology (IOZ) have cracked the code of...
VIVUS launches QSYMIA in the UAE
VIVUS has received market approval of QSYMIA (phentermine and topiramate extended-release capsules) CIV in the United Arab Emirates (UAE)...
REDEFINE 2: CagriSema demonstrates superior weight loss
Outcomes from the from REDEFINE 2, a phase 3 trial in the global REDEFINE programme, have revealed the trial achieved its primary...
First patient dosed in the clinical study of bofanglutide injection for overweight or obesity
The first participant has been successfully dosed in Gan & Lee Pharmaceuticals’ Phase 2 clinical trial of bofanglutide (GZR18) injection,...
More than 65 organisations advocate for coverage of obesity care in open letter to leading employers as Obesity Care Week urges expanded coverage to include FDA-approved obesity medications
The Alliance for Women's Health and Prevention's (AWHP) EveryBODY Covered campaign delivered an open letter to executives at top...
Naturally occurring BRP molecule rivals semaglutide in weight loss but without side effects
Stanford University Medical Center researchers have identified a naturally occurring molecule, BRP, which appears similar to semaglutide...
Melatonin improves muscle energy efficiency offering a potential therapy to combat diabesity
An international study led by the University of Granada (UGR) has revealed that melatonin, known for its ability to regulate the...
The cause of leptin resistance and how to reverse it
Researchers at Rockefeller University have discovered a neural mechanism involved in leptin resistance and, crucially, a way to reverse...
Industry
All caught up?
New: Directory
Discover global suppliers of specialist bariatric services, treatments, products, and medical equipment.
Events
Tweets
bottom of page